Seeking Alpha

In a major policy reversal, the DoJ filed an amicus brief late yesterday saying human DNA and...

In a major policy reversal, the DoJ filed an amicus brief late yesterday saying human DNA and other genes shouldn't be eligible for patents. It's unclear whether the Patent Office will adopt the position, which could potentially force some biotech firms to change the way they develop drugs.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)